Key Highlights

  • Rocket Lab completed a $1.944 billion ATM offering of 29.3 million shares and cancelled its $3.6 billion bridge Loan on Sep 15.
  • Iridium's $1.775 billion term loan was amended to stay in place after the change of control, with a Rocket Lab USA guarantee at closing.
  • Iridium stockholders vote on Sep 24; the deal is expected to close in mid-2027, while the Neutron debut window for 2026 is narrowing.
  • The stock closed at $71.98 on Sep 22, well below the roughly $94 level it reached after the deal was announced, and has traded between $37.57 and $151.00 over the past 52 weeks.

Rocket Lab (NASDAQ:RKLB) has lined up all the money it needs for its roughly $8 billion Acquisition of Iridium Communications (NASDAQ:IRDM), and it did so without keeping a large bridge loan on its books. In a Sep 15 release, the company said it had completed a $1.944 billion at-the-market (ATM) Equity program, secured an amendment to Iridium's existing $1.775 billion term loan so it can stay in place after the change of control, and terminated a $3.6 billion senior secured bridge Facility it had arranged when the deal was signed.

The funding combines three pieces. The ATM program issued 29.3 million new shares, which implies an average gross price of roughly $66 per share. Iridium's term loan becomes permanent financing backed by Iridium's own cash flow, with Rocket Lab USA, the company's main operating subsidiary, providing an unsecured guarantee once the deal closes. Rocket Lab's other unrestricted cash covers the remainder. Together, the company said, these amounts are enough to pay the cash consideration, repay certain other Iridium Debt and cover fees at closing.

For shareholders, the trade-off is clear. Replacing a secured bridge loan with equity and existing low-cost debt reduces financing risk and interest costs, but the new shares dilute existing holders. The stock closed at $71.98 on Sep 22, well below the roughly $94 it reached after the deal was announced in late June.

How the Financing Came Together

Rocket Lab announced the Iridium agreement on June 29. Under the terms, Iridium stockholders are to receive $54 per share, made up of $27 in cash and Rocket Lab stock, with the exchange ratio subject to a collar between $67.50 and $112.50 per Rocket Lab share. The deal implied an Enterprise value of about $8.0 billion and a premium of about 24% to Iridium's prior close.

At signing, Rocket Lab had obtained commitments for the $3.6 billion bridge facility. The Sep 15 steps removed the need to draw on it. Rocket Lab said any ATM proceeds not used for the acquisition would go toward future growth, potential acquisitions and general corporate purposes. The company now operates as Rocket Lab Corporation, with Rocket Lab USA as its primary operating subsidiary.

Record Revenue and a $2.36 Billion Backlog

The financing arrives on the back of strong operating momentum. In its Aug 10 second-quarter report, Rocket Lab posted record revenue of $234 million, up 62% year over year, and a record Backlog of $2.36 billion, up 137%. The net loss narrowed to $49.3 million, or $0.08 per share, from $66.4 million a year earlier. Founder and chief executive Sir Peter Beck said the company had entered more than $1 billion of new contracts across launch and space systems in the third quarter so far.

For the third quarter, the company guided to revenue of $250 million to $265 million, GAAP gross margins of 29% to 31% and an adjusted EBITDA loss of $17 million to $23 million. It also closed the acquisitions of Mynaric (NASDAQ:MYNA) and Motiv during the period and won a contract worth about $397 million to deliver spacecraft launched on Neutron for the U.S. Space Force's Space-Based Airborne Moving Target Indicator program.

Why Iridium Fits the Plan

Iridium operates a global low Earth orbit satellite network with valuable L-band spectrum and a large partner ecosystem. Rocket Lab's aim is to become a vertically integrated company that designs, builds, launches and operates its own constellations, similar in concept to SpaceX's model with Starlink. The deal has been framed as a move to take on SpaceX. Iridium brings recurring service revenue and free cash flow, which would complement Rocket Lab's launch and satellite Manufacturing businesses, where revenue is more contract-driven.

Neutron Timing and the Competitive Picture

The medium-lift, reusable Neutron rocket remains the biggest swing Factor in Rocket Lab's launch business. The company said production of the Stage 1 tank is aligned with delivering Neutron to its Wallops Island, Virginia launch pad in the fourth quarter of 2026. However, Beck said on the Aug 10 Earnings Call that the window for a 2026 debut is narrowing, raising the possibility that the first flight slips into 2027. Neutron was originally targeted for 2024.

Beyond Neutron, the company said it secured more than $437 million of new launch contracts across Electron, HASTE and Neutron during the second quarter and in post-quarter signings, lifting its launch backlog to more than 90 launches. It also introduced GHOST, a globally deployable launch system, with a first suborbital launch from Kodiak, Alaska planned for 2027.

In launch, Rocket Lab competes most directly with SpaceX, as well as with Blue Origin, United Launch Alliance and Firefly Aerospace (NASDAQ:FLY). In satellite communications, the Iridium network competes with Starlink, Viasat (NASDAQ:VSAT) and other operators.

Risks Worth Weighing

  • Deal completion: The acquisition still needs Iridium stockholder approval and regulatory clearances, and closing is not expected until mid-2027.
  • Litigation: Iridium has faced Shareholder lawsuits alleging disclosure gaps in its Merger proxy; Iridium has disputed the claims while adding disclosures.
  • Dilution: The ATM shares and the stock portion of the merger consideration will add to Rocket Lab's share count.
  • Execution: Further Neutron delays could push back launch revenue and the Space Force missions tied to it.
  • Integration and leverage: Rocket Lab will take on Iridium's term loan through its guarantee and must integrate a large operating Business alongside recent acquisitions.
  • Volatility: The shares have traded between $37.57 and $151.00 over the past 52 weeks.

Iridium's Special Meeting and the Neutron Countdown

The nearest catalyst is Iridium's special stockholder meeting on Sep 24, 2026, where holders will vote on the merger. After that, investors will watch regulatory reviews ahead of a mid-2027 close, Neutron's arrival at the pad in the fourth quarter and any update on its first launch date.

Rocket Lab's third-quarter report is expected around Nov 9, though the company has not confirmed that date; results will be measured against the $250 million to $265 million revenue guidance and backlog growth.